LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.625
-0.005 (-0.31%)
Oct 31, 2025, 4:00 PM EDT - Market closed
LAVA Therapeutics Market Cap
LAVA Therapeutics has a market cap or net worth of $42.75 million as of October 31, 2025. Its market cap has increased by 1.59% in one year.
Market Cap
42.75M
Enterprise Value
-13.29M
1-Year Change
1.59%
Ranking
Category
Stock Price
$1.63
Market Cap Chart
Since the IPO on March 25, 2021, LAVA Therapeutics's market cap has decreased from $380.28M to $42.75M, a decrease of -88.76%. That is a compound annual growth rate of -37.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 42.88M | 71.44% |
| Dec 31, 2024 | 25.01M | -39.79% |
| Dec 29, 2023 | 41.54M | -54.86% |
| Dec 30, 2022 | 92.01M | -35.10% |
| Dec 31, 2021 | 141.77M | -62.72% |
| Mar 25, 2021 | 380.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.14B |
| Johnson & Johnson | 455.48B |
| AbbVie | 403.13B |
| UnitedHealth Group | 312.23B |
| AstraZeneca | 255.76B |
| Novartis AG | 237.42B |
| Novo Nordisk | 222.08B |
| Abbott Laboratories | 216.98B |